BioVie enters $6M private placement with controlling stockholder Acuitas Group; issues shares and warrants

BIOVIE INC.

Issued 3,636,364 shares at $1.65/share to Acuitas Group Holdings, LLC, a related party controlled by chairman Terren Peizer.
Warrant to purchase 7,272,728 shares at $1.82 exercise price, five-year term.
Aggregate purchase price approximately $6 million; expected closing on or about August 15, 2022.
Proceeds to be used for working capital; registration rights to be amended to cover resale of shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.